A randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivors
Jill E. Lavigne(St. John Fisher College), Karen M. Mustian(University of Rochester Medical Center), Raymond Lord(Michigan Cancer Research Consortium), Jennifer Mathews(St. John Fisher College), Charles E. Heckler(University of Rochester Medicine), Gary R. Morrow(University of Rochester Medical Center), E. Henry Amos(St. John Fisher College), Andrew Jacobs(Virginia Mason Medical Center), Jeffrey J. Kirshner(American Society of Clinical Oncology), Oxana Palesh(Virginia Commonwealth University)
Cited by 47
Related Papers
Cancer-Related Fatigue, Version 2.2015
|Journal of the National Comprehensive Cancer Network|2015|951
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*
|Journal of Clinical Oncology|2001|819
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
|Journal of Clinical Oncology|1999|670